Conatus Pharmaceutic (CNAT)

0.556  +0 (+0.18%)

After market: 0.54 -0.02 (-2.88%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Conatus Pharmaceutic

NASDAQ:CNAT (5/26/2020, 7:04:43 PM)

After market: 0.54 -0.02 (-2.88%)

0.556

+0 (+0.18%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap18.44M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

CNAT Daily chart

Company Profile

Conatus Pharmaceuticals, Inc. is a biotechnology company. It is focused on developing and commercializing medicines to treat liver disease. The Company is developing its lead compound, emricasan, for the treatment of patients in orphan populations with chronic liver disease and acute exacerbations of chronic liver disease. Conatus Pharmaceuticals, Inc. is headquartered in San Diego, California.

Company Info

Conatus Pharmaceutic

16745 W. Bernardo Dr. Suite 250

San Diego CA 92127

P: 858-376-2600

CEO: Steven J. Mento

CNAT News

News Image4 years ago - Seeking AlphaHistogen completes tie-up with Conatus Pharma (NASDAQ:CNAT)

Histogen (HSTO) has finalized its merger with Conatus Pharmaceuticals (NASDAQ:CNAT). The combined company with do business under the Histogen name with shares trading under the HSTO ticker starting to

News Image4 years ago - StockNews.comBest & Worst Performing Small Cap Stocks for May 21, 2020

XTNT – XTNT leads the way today as the best performing small cap stock, closing up 160.28%.

News Image4 years ago - Conatus Pharmaceuticals Inc.Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Histogen and the Required Reverse Stock Split
News Image4 years ago - StockNews.comBest & Worst Performing Small Cap Stocks for May 14, 2020

SNNA – SNNA leads the way today as the best performing small cap stock, closing up 34.46%.

News Image4 years ago - Conatus Pharmaceuticals Inc.; Histogen Inc.Histogen Publishes Preclinical Data on its HST 004 Spinal Disc Program
News Image4 years ago - Conatus Pharmaceuticals Inc.; Histogen Inc.Histogen Receives US FDA IND Approval to Initiate Phase 1b/2a Trial of HST 001 in Androgenic Alopecia

CNAT Twits

Here you can normally see the latest stock twits on CNAT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example